LiteraturaPoliklinika, poliklinika, Poliklinika Harni, poliklinika harni, poliklinika dr. Harni, ginekološka poliklinika, ordinacija, ginekološka ordinacija, ginekolog, dobar ginekolog, dobri ginekolozi,doktor, dobri doktori, zagreb, dubrava, polikklinika, poliklinka, poliliklinika, marni, dr. Marni, poliklinika marni, vesna, vesna harni, dr, poliklinike u zagrebu, ginekologija, spolne bolesti, adolescenti, kontracepcija, menopauza, ispadanje kose, miomi, ciste, osteoporoza, dijagnoza, ginekologija, spolne bolesti, adolescenti, kontracepcija, menopauza, ispadanje kose, miomi, ciste, osteoporoza, dijagnoza, poliklinika, ordinacija, ginekolog, klamidija, HPV, HPV infekcija, spolne infekcije, kondom, spirala, IUD, mirena, sterilizacija, ultrazvuk, PAPA, PAPA test, kolposkopija, CIN, CIN1, CIN2, CIN3, LETZ, konizacija, vrat maternice, cerviks, grlić, menstruacijski ciklus, menstruacija, oligomenoreja, polimenoreja, amenoreja, endometrioza, PMS, anovulacija, ovulacija, hitna kontracepcija, HNL, hormonsko liječenje, hormonsko nadomjesno liječenje, hormonska nadomjesna terapija, trihomonas, kandida, herpes, genitalni herpes, hepatitis B, gonoreja, gardnerela, gardnerella, bakterijska vaginoza, miomi, ciste, miom, uterus, vagina, maternica, rodnica, vulva, stidnica, ovarij, jajnik, jajnici, jajovod,
Kontakt Forum RSS
Ginekologija
Brojni znanstvenici istražuju uzroke, a drugi nastoje pronaći brzu i učinkovitu pomoć za liječenje ginekoloških oboljenja. Većina njih usmjerena je na tjelesne smetnje, dok je manje učinjeno na razjašnjenju psiholoških mehanizama povezanih s ovim tegobama.

Literatura

Datum zadnje izmjene: 7. siječnja 2017.




Kuhn H, Jung-Hoffmann C. Kontrazeption. Ferdinand Enke Verlag Stuttgart 1996

Neulen J. Kontrazeption: Welche Methoden stehen zur Verfügung? Frauenarzt 2003; 44(3):294-298

Attar E, Gokdemirel S, Serdaroglu H, Coskun A. Natural contraception using the Billings ovulation method. Eur J Contracept Reprod Health Care. 2002; 7(2):96-9.

Shivanandan M. Natural family planning: folly or fulfillment? Marriage Fam Living. 1976; 58(10):2-5.

France JT. The ovulation method of family planning. IPPF Med Bull. 1973; 7 (3):2-3.

Stagge P. Sicherheit von Kondomen. TW Gynäkologie 1996; 9: 438-446

Nutz M. Das Diaphragma als sichere Alternative. hautnah gynäkologie + geburtshilfe 1997; 4: 163-165

Bitzer J. Kontrazeption bei Drogenabhängigen. T&E Gynäkologie 1998; 210-215

Felberbaum R, Diedrich K. Orale Kontrazeptiva - Vorteile und Risiken. Gynäkologe, 1997; 30: 305-313

Braendle W. Zur laufenden Pillendiskussion: Sorgfältige Familienanamnese notwendig. hautnah gynäkologie + geburtshilfe 1997; 1: 16-19

Geurts TBP, Goorisen EM, Sitsen JMA. Übersicht über Arzneimittelinteraktionen mit oralen Kontrazepiva. The Parthenon Publishing Group London Casterton new York, 1994

Kemmeren JM, Algra A, Grobbee DE. Effect of second and third generation oral contraceptives on lipid metabolism in the absence or presence of the factor V Leiden mutation. J Int Med 2001; 250 (5):441-448

Vasilakis-Scaramozza C, Jick H. Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives. Lancet 2001; Vol 358 (9291):1427-29

Gris JC, Jamin C. Benifla JL, Quere I, Madelenat P, Mares P. APC resistance and third-generation oral contraceptives: Acquired resistance to activated protein C, oral contraceptives and the risk of thromboembolic disease. Hum Reprod 2001; 16 (1):3-8

Karck U, Breckwoldt M.
Niedrig dosierte orale Kontrazeptiva und Knochendichte. Therapeutische Umschau, Band 58, 2001; Verlag Hans Huber, Bern

Kemmeren JM, Algra A, Grobbe DE. Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ 2001; 323 (7305): 131-134

Eisenburg J. Lebertumoren unter Kontrazeptiva. Dt Ärtztebl 88; 1991; Heft 18: A1569-A1578

Scalori A, Tavani A, Gallus S, La Vecchia C, Colombo M. Oral contraceptives and the risk of focal nodular hyperplasia of the liver: A case-control study. Am J Obstet Gynecol 2002, Vol 186 (2): 195-197

Gram I, Macaluso M, Stalsberg H. Oral contraceptive use and the incidence of cervical intraepithelial neoplasia. Am J Obstet Gynecol 1992; 167: 40-44

Coker AL, McCann MF, Hulka BS, Walton LA. Oral contraceptive use and cervical intraepithelial neoplasia. J Clin Epidemiol 1992; Vol 45 No 10: 1111-1118

Delgado-Rodrigues, Sillero-Arenas M, Martin-Moreno JM, Galvez-Vargs R. Oral contraceptives and cancer of the cervix uteri. Acta Obstet Gynecol Scand 1992; 71: 368-376

Rushton L, Jones DR.
Oral contraceptive use and breast cancer risk: a meta-analysis of variations with age at diagnosis, parity and total duration of oral contraceptive use. Br J Obstet Gynaecol 1992; Vol 99: 239-246.

Wingo P; Lee NC, Ory HW, Beral V; Pereson HB, Rhodes P. Age-Specific Differences in the Relationship between Oral Contraceptive Use and Breast Cancer. Cancer suppl 1993; Vol 71 (4):1506-1516


Schildkraut JM, Calingaert B, Marchbanks PA, Moorman PG, Rodriguez GC. Impact of Progestin and Estrogen Potency in Oral Contraceptives on Ovarian Cancer Risk. J Natl Cancer Inst 2002; Vol 94 (1): 32-38

Smallwood GH; Meador ML; Lenihan JP. Shangolf GA et al. Efficacy and safety of a transdermal contraceptives system Obstet Gynecol 2001; 98 (5 PT 1): 799-805

Sicat BL.
Ortho Evra, a new contraceptive patch. Pharmacotherapy. 2003;23(4):472-80.

Zite NB, Shulman LP.
New options in contraception for teenagers. Curr Opin Obstet Gynecol. 2003; 15(5):385-9.

Kuhl H. Neue Gestagene - ihre Vor- und Nachteile. Therapeutische Umschau, Band 58; Verlag Hans Huber Bern, 2001

Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM. Injectable Hormone Contraception and Bone Density: Results from s Prospective Study. Epidemiology 2002; Vol 13 (5): 581-587

Pankratz-Hauer M, Pauli F. Implanon: Lokalisation und Entfernung. Frauenarzt 2003; 44 (3): 310-313

Edwards JE, Moore A. Implanon: a review of clinical studies. British Journal of Family Planning 1999; 4:3-16

Pasquale SA, Sinofsky FE. Pharmacology of Implanon: A Two Year Study Evaluating Absorption, Stabilization of Levels and Elimination Rate. ASRM Meeting 1996

Koch UJ, Tauber P, Wagner H. Empfehlungen des Arbeitskreises "Intrauterinpessare" Nourypharma GmbH Oberschleißheim 1998.

Winkler UH.
Vasovagale Reaktionen beim Legen eines Intrauterinpessars. gynäkol.prax. 1996; 20: 127-128

Nagrani R, Bowen-Simpkins P, Barrington JW. Can the levonorgestrel intrauterine system replace surgical treatment for the management of menorrhagia? Br J Obstet Gynaecol 2002, Vol. 109 (3): 345-347

ACOG practice bulletin Nr 46. Vorteile und Risiken der Sterilisation. Frauenarzt 2004; 45 (3):204-212

Runnebaum B. Kontrazeption in den Wechseljahren der Frau. hautnah gynäkologie + geburtshilfe 1997; 1: 20-21

Beller FK. Notfall Kontrazeption. Eine Neubesinnung der Morning after Pill. Seminar des Frauenarztes, Frauenarzt 1998; 109-113

Spycher Ch, Bigler G. Postokoitale Notfall-Kontrazeption. Therapeutische Umschau, Band 58; Verlag Hans Huber Bern, 2001

ACOG practice bulletin. Emergency oral contraception. Number 25. Int J Gynecol Obstet 2002; Vol 78: 191-198
Literatura